Company / SG&A per Share
Supernus Pharmaceuticals, Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$8.71
FY2025
5-year range
$5.76 / $8.71
FY2021-FY2025
Trend
+48.2%
vs FY2024
Sector context
#20 of 210
Health Care
What the data says
Among 210 Health Care companies, Supernus Pharmaceuticals, Inc. is in the bottom 10% for sg&a per share. SG&A per Share returned to growth in FY2025 after 2 years of decline, reaching $8.71.
Based on SEC 10-K filings.
8.71 in FY2025 with a 5-year CAGR of +17.9%. Top quartile in the Health Care sector.
Increased from $6.06 to $8.71 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +7.1%
- 5-Year CAGR
- +17.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 210This company $8.71 Sector average $40.75
▼
-78.6% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 48.2% year-over-year.
- Ranks #20 out of 210 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.71 | +48.2% |
| FY2024 | $5.88 | -3.0% |
| FY2023 | $6.06 | -14.4% |
| FY2022 | $7.08 | +22.9% |
| FY2021 | $5.76 | +50.9% |
| FY2020 | $3.82 | +30.4% |
| FY2019 | $2.93 | +41.8% |
| FY2018 | $2.07 | +15.9% |
| FY2017 | $1.78 | +20.3% |
| FY2016 | $1.48 | -28.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026